Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02502045 · ClinicalTrials.gov registry record · NA
Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02502045 is a NA study that has completed, run by Yale University. The registered enrollment target is 18 participants.
The verdict
NCT02502045, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Determine effect and duration of effect of timed therapeutic light compared to control light on parameters of circadian rhythmicity, physiologic plasticity, sleep, and global function in women with Alzheimer's Disease.
Interventions
- DEVICE Morning Simulated Sunlight
- DEVICE Non-therapeutic Red Light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02502045
The ClinicalTrials.gov registry entry for NCT02502045 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Morning Simulated Sunlight is the first listed.
NCT02502045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02502045 about?
NCT02502045 is a clinical study titled "Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's". Determine effect and duration of effect of timed therapeutic light compared to control light on parameters of circadian rhythmicity, physiologic plasticity, sleep, and global function in women with Alzheimer's Disease.
What is the current status of trial NCT02502045?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2012-05. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02502045?
The interventions under investigation include: Morning Simulated Sunlight (DEVICE), Non-therapeutic Red Light (DEVICE).
Who is sponsoring clinical trial NCT02502045?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.